Q&A: Forbion Capital Partners' Sander Slootweg
Life-sciences-focused venture firm Forbion Capital Partners recently held a €360m final close for its fourth flagship fund, surpassing its initial hard-cap of €350m. Managing partner Sander Slootweg speaks to Francesca Veronesi about the fundraising process, the firm's 'build' strategy and the European life sciences venture market
More on Benelux
Private wealth to increase allocation to private equity
High-net-worth individuals and family offices are hunting for yield, concerned about low interest rates and market volatility
Carlyle's Saverglass carves out MD Verre from Vidrala
Saverglass intends to invest €50m over the next three years to convert MD Verre's production
Ardian's Dedalus carves out Agfa-Gevaert's healthcare IT business
Dedalus buys the business for an EV of €975m, with the aim of creating a healthcare software group
NPM Capital et al. in €250m series-C for Picnic
Company will use the fresh capital to develop a robotised distribution centre in Utrecht
Latest News
Latour collects €800m for third fund
Vehicle is expected to hold a final close in March 2020, Unquote understands
Waterland-backed Hansefit combines with BFNL
Merger of German and Dutch peers will result in a client base of 3,500 companies
BlackFin closes third buyout fund on €985m
Fund's predecessor, BlackFin Financial Services Fund II, closed on €400m in 2016
Afinum acquires Fast LTA
GP will support the Munich-based software company's growth by broadening its product offering